Crossmark

Double-masked, sham and placebo-controlled trial of corneal cross-linking and topical difluprednate in the treatment of bacterial keratitis: Steroids and Cross-linking for Ulcer Treatment Trial (SCUT II) study protocol

Crossref DOI link: https://doi.org/10.1136/bmjophth-2021-000811

Published Online: 2021-11-29

Published Print: 2021-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Radhakrishnan, Naveen

Prajna, Venkatesh N https://orcid.org/0000-0003-2019-4044
Prajna, Lalitha S https://orcid.org/0000-0001-5379-7015
Venugopal, Anitha

Narayana, Shivanandha

Rajaraman, Revathi

Amescua, Guillermo

Porco, Travis C https://orcid.org/0000-0001-8813-3171
Lietman, Thomas M

Rose-Nussbaumer, Jennifer https://orcid.org/0000-0002-4905-2528
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct04097730 at ClinicalTrials.gov

Documents that mention this clinical trial

Double-masked, sham and placebo-controlled trial of corneal cross-linking and topical difluprednate in the treatment of bacterial keratitis: Steroids and Cross-linking for Ulcer Treatment Trial (SCUT II) study protocol
https://doi.org/10.1136/bmjophth-2021-000811
Funding

Funding for this research was provided by:

Research to Prevent Blindness (Institutional grant at UCSF)

National Eye Institute (K23 EY025025)

National Eye Institute (UG1 EY028518)
License Information

License valid from 2021-11-29

Document is current

Any future updates will be listed below